Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Shares Outstanding (Weighted Average): 2018-2024

Historic Shares Outstanding (Weighted Average) for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to $27.1 million.

  • Arcturus Therapeutics Holdings' Shares Outstanding (Weighted Average) rose 0.42% to $27.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.2 million, marking a year-over-year increase of 0.42%. This contributed to the annual value of $27.1 million for FY2024, which is 1.36% up from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Shares Outstanding (Weighted Average) stood at $27.1 million for FY2024, which was up 1.36% from $26.7 million recorded in FY2023.
  • Arcturus Therapeutics Holdings' Shares Outstanding (Weighted Average)'s 5-year high stood at $27.1 million during FY2024, with a 5-year trough of $24.5 million in FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $26.8 million, with a median of $26.7 million in 2023.
  • Data for Arcturus Therapeutics Holdings' Shares Outstanding (Weighted Average) shows a peak YoY soared of 61.80% (in 2020) over the last 5 years.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Shares Outstanding (Weighted Average) (Yearly) stood at $24.5 million in 2020, then grew by 7.62% to $26.4 million in 2021, then climbed by 0.50% to $26.5 million in 2022, then rose by 0.87% to $26.7 million in 2023, then rose by 1.36% to $27.1 million in 2024.